SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling

@article{Qin2017SNORA74BGS,
  title={SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling},
  author={Yiyu Qin and Li Meng and Yang Fu and Zhiwei Quan and Mingzhe Ma and Ming‐zhe Weng and Zhengdong Zhang and Cuixiang Gao and Xinghua Shi and Koulan Han},
  journal={Oncotarget},
  year={2017},
  volume={8},
  pages={19980 - 19996}
}
Small nucleolar RNAs (snoRNAs) have been implicated in the development of many cancers. We therefore examined the differential expression of snoRNAs between gallbladder cancer (GBC) tissues and matched adjacent non-tumor tissues using expression microarray analysis with confirmation by quantitative real-time PCR (qRT-PCR). Western blot analysis showed that SNORA74B levels were higher in GBC than non-tumor tissues. SNORA74B expression was positively associated with local invasion, advanced TNM… 

Figures and Tables from this paper

Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

The data demonstrated that SNORA38B functioned as an oncogene in NSCLC both in vitro and in vivo at least in part by regulating the GAB2/AKT/mTOR pathway via directly binding to E2F1.

SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells

This study revealed that snoRNA host gene 25 (SNHG25) expression was upregulated in NB cells and promoted NB progression through SNORA50C/HDAC1 pathway, and might provide a novel sight for NB treatment.

Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway

It is found that higher levels of NFAT5 expression predict a good prognosis, suggesting thatNFAT5 is a potential tumor-suppressing gene, and it is verified that NFAT 5 promotes hepatoma cell apoptosis and inhibits cell growth in vitro.

Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer

The present review recapitulates the association of various ncRNAs in the initiation and progression of GBC and the development of novel therapeutic strategies by exploring their functional and regulatory role.

Upregulation of DARS 2 by HBV promotes hepatocarcinogenesis through the miR-30 e-5 p / MAPK / NFAT 5 pathway

It is found that higher levels ofNFAT5 expression predict a good prognosis, suggesting that NFAT5 is a potential tumor-suppressing gene, and the results showed that HBV could suppress NFAT 5 expression by inducing hypermethylation of the AP1-binding site in the NFAT4 promoter in hepatoma cells.

Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies

The different aspects of snoRNAs in B-cell malignancies are discussed and their role in oncogenic transformation, which may be useful for the development of novel diagnostic biomarkers or therapeutic targets, is reported on.

Small Nucleolar RNAs: Insight Into Their Function in Cancer

The biogenesis and functions of snoRNAs, as well as the association of snORNAs in different types of cancers and their potential roles in cancer diagnosis and therapy are summarized.

References

SHOWING 1-10 OF 40 REFERENCES

Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer

SNORD78 may be a potential therapeutic target for NSCLC after a great upregulation of SNORD78 was observed in cancer tissues compared to their adjacent normal tissues.

Forkhead Box L1 Is Frequently Downregulated in Gallbladder Cancer and Inhibits Cell Growth through Apoptosis Induction by Mitochondrial Dysfunction

It is suggested that dysregulated FOXL1 is involved in tumorigenesis and progression of GBC and may serve as a predictor of clinical outcome or even a therapeutic target for patients with GBC.

Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer

The findings suggest that dysregulation of SNHG20 participates in CRC progression and may serve as a potential therapeutic target in CRC patients.

Long Noncoding RNA GCASPC, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase-Dependent Cell Proliferation in Gallbladder Cancer.

GCASPC levels were significantly lower in gallbladder cancer than adjacent nontumor tissues and were associated with tumor size, American Joint Committee on Cancer tumor stage, and patient outcomes, illuminating a new basis for understanding its pathogenicity.

Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer.

SNHG1 may be a novel ncRNA in early diagnosis in lung cancer and may represent a new biomarker and a potential therapeutic target for NSCLC intervention, according to data indicated.

Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol

This study is the first to demonstrate that SNHG5 is a critical and powerful regulator that is involved in GC progression through trapping MTA2 in the cytosol, thereby interfering with the formation of the nucleosome remodeling and histone deacetylation complex.

Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer

The role and mechanism of PHLPP and Survivin in GBC cells are revealed and proposed strategies for gene therapies targeting the miR-495 / PHL PP / AKT / Survivin regulatory pathway are proposed.

PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.

PHLPP1 and PHLPP2 dephosphorylate RAF1 to reduce its signaling, increase the invasive and migratory activities of CRC cells, and activate the epithelial-mesenchymal transition.

Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis

SNORA42 activation could have an oncogenic role in lung tumorigenesis and provide potential diagnostic and therapeutic targets for the malignancy.